Cholangiocarcinoma
Overview
Cholangiocarcinoma is also a rare cancer with approximately 5,000 cases diagnosed each year in the US. Patients are usually in theirs sixties. Risk factors include primary sclerosing cholangitis, hepatolithiasis, choledochal cysts, or liver fluke infection. Symptoms include weigh loss, jaundice, right upper quadrant pain, fever, and palpable mass. Diagnosis and imaging include liver MRI, MRCP, or abdominal CT. An ERCP is often needed for diagnosis.
Treatment Options
Treatment options include surgery, adjuvant chemotherapy, chemoradiation, radiofrequency ablation or chemotherapy alone. Chemotherapy agents include 5-FU, oxaliplatin, cisplatin, and gemzar.
Cholangiocarcinoma Specialists
Dr. Raymond Tsao
Dr. Tsao is board certified in medical oncology and hematology. He is currently seeing patients with all types of cancer, with a focus on hematologic and gastrointestinal malignancies, including esophageal, stomach, colorectal and pancreatic cancer. Dr. Tsao is a member of the American Society of Clinical Oncology and American Society of Hematology.
Dr. Vijay Narendran
Dr. Narendran is board certified in medical oncology and hematology. Dr. Narendran treats a variety of cancers and has a special interest in gastrointestinal and hematologic malignancies. Dr. Narendran is a member of the American Society of Clinical Oncology and the American Society of Hematology.
Kelly Foster, MD
Dr. Foster is board certified in medical oncology, internal medicine and palliative medicine. She is currently seeing patients with all types of cancer, with a focus on breast and gastrointestinal cancers (gastric, esophageal, pancreatic, hepatobiliary, colon, anal). She is a member of the American Society of Clinical Oncology.
